documents: FDA-2018-N-1262-0023

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2018-N-1262-0023 FDA FDA-2018-N-1262 Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; OPZELURA (ruxolitinib) Notice General Notice 2024-09-11T04:00:00Z 2024 9     2024-09-11T13:16:31Z 2024-20556 0 0 09000064866ea193

Links from other tables